Yi-Lin Dan

Yi-Lin Dan

Auto-generated profile, based on publicly available information

Yi-Lin Dan

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
QWQian Wu
Qian Wu
YDYi-Lin Dan
Yi-Lin Dan
YHYi-Sheng He
Yi-Sheng He
KXKun Xiang
Kun Xiang
YHYu-Qian Hu
Yu-Qian Hu
HPHai-Feng Pan
Hai-Feng Pan
Background: Meteorin-like (Metrnl) is a newly identified adipokine implicated in the pathogenesis of type 2 diabetes mellitus (T2DM), yet data on the circulating levels of Metrnl in patients with T2DM are controversial. To derive a more precise estimation on circulating Metrnl levels in T2DM patients, we conducted this meta-analysis. Methods: The existing studies on the circulating levels of Metrnl in patients with T2DM published up to 16 January 2020 were comprehensively retrieved from PubMed, Web of Science, EMBASE, and The Cochrane library database. Pooled standard mean difference (SMD) with 95% confidence interval (CI) was calculated using random-effects model. Heterogeneity was assessed and quantified by Cochrane’s Q and I2 statistic. All statistical analyses were performed using Stata 12.0 software. Results: Nine studies with 867 T2DM patients and 831 normal glucose tolerance (NGT) controls were included in the final analysis according to the inclusion criteria. No significant difference in circulating Metrnl levels was found between T2DM patients and NGT individuals (pooled SMD = -0.429, 95% CI = -1.077 to 0.219). Compared to controls, circulating Metrnl levels were significantly higher in the subgroups with BMI <25 kg/m2, using plasma sample and patient sample size ≥100, while circulating Metrnl levels were significantly lower in subgroups with age ≤50 years and homeostatic model assessment for insulin resistance (HOMA-IR) ≥4. Conclusions: This meta-analysis indicates no significant change in circulating Metrnl levels in T2DM patients. However, this result may be influenced by age, BMI, sample type, HOMA-IR and patients sample size. Further longitudinal studies are warranted to offer more insights into the relationship between Metrnl and T2DM.

6 April 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
GWGuo-Cui Wu
Guo-Cui Wu
STShasha Tao
Shasha Tao
CZChanna Zhao
Channa Zhao
YMYan-Mei Mao
Yan-Mei Mao
QWQian Wu
Qian Wu
HPHai-Feng Pan
Hai-Feng Pan

25 April 2024 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
YDYi‐Lin Dan
Yi‐Lin Dan
YYYi‐Qun Yang
Yi‐Qun Yang
DZDong‐Cheng Zhu
Dong‐Cheng Zhu
LBLin Bo
Lin Bo
SLShu-Feng Lei
Shu-Feng Lei

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
STShasha Tao
Shasha Tao
YDYi-Lin Dan
Yi-Lin Dan
GWGuo-Cui Wu
Guo-Cui Wu
QZQin Zhang
Qin Zhang
TZTian-Ping Zhang
Tian-Ping Zhang
HPHai-Feng Pan
Hai-Feng Pan
Background. Recently, increasing studies have revealed that leptin is involved in the development of rheumatoid arthritis (RA). This study is aimed at exploring the association of leptin gene single nucleotide polymorphisms (SNPs) with susceptibility to RA in a Chinese population. Methods. We recruited 600 RA patients and 600 healthy controls from a Chinese population and analyzed their three leptin SNPs (rs10244329, rs2071045, and rs2167270) using the improved Multiplex Ligase Detection Reaction (iMLDR) assays. The associations of these SNPs with clinical manifestations of RA were also analyzed. Enzyme‐linked immunosorbent assay (ELISA) was performed for plasma leptin determination. Results. No significant difference in either allele or genotype frequencies of these three SNPs between RA patients and healthy controls was observed (all P > 0.05). Association between the genotype effects of dominant, recessive models was also not found (all P > 0.05). No significant difference in plasma leptin levels was detected between RA patients and controls (P > 0.05). Conclusion. Leptin gene (rs10244329, rs2071045, and rs2167270) polymorphisms are not associated with RA genetic susceptibility and its clinical features in the Chinese population.